HKD 3.28
(9.33%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 524.01 Million CNY | 11.55% |
2022 | 525.17 Million CNY | 838.1% |
2021 | 55.98 Million CNY | 0.0% |
2020 | - CNY | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 86.66 Million CNY | -25.88% |
2024 Q2 | 86.66 Million CNY | 0.0% |
2023 Q2 | 145.07 Million CNY | 0.0% |
2023 FY | 585.85 Million CNY | 11.55% |
2023 Q3 | 116.93 Million CNY | -19.4% |
2023 Q1 | 145.07 Million CNY | -2.06% |
2023 Q4 | 116.93 Million CNY | 0.0% |
2022 FY | 525.17 Million CNY | 838.1% |
2022 Q3 | 148.12 Million CNY | 0.0% |
2022 Q4 | 148.12 Million CNY | 0.0% |
2021 FY | 55.98 Million CNY | 0.0% |
2020 FY | - CNY | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Uni-Bio Science Group Limited | 392.81 Million HKD | -33.398% |
CK Life Sciences Int'l., (Holdings) Inc. | 947.7 Million HKD | 44.707% |